GORE VIABAHN Endoprosthesis with Heparin VBH091502ARecalls & reported problems
W. L. Gore & Associates, Inc. · VIABAHN SX ENDO HEPARIN 35 9mmX15cm 9Fr 120cmCath · Class 3 · Implant
All models of GORE VIABAHN Endoprosthesis with Heparin (62)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00733132623198), received between Sep 6, 2018 and Aug 6, 2020 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Break1
- Complete Blockage1
- Material Integrity Problem1
- Off-Label Use1
Patient problems
- Cramp(s)1
- Foreign Body In Patient1
- Ischemia1
- No Known Impact Or Consequence To Patient1
- Numbness1
- Pain1
- Skin Discoloration1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 6, 2020Break; Material Integrity Problem; Material Integrity Problem
THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2020, THE PATIENT UNDERWENT TREATMENT OF A POPLITEAL ANEURYSM USING GORE® VIABAHN® ENDOPROSTHESIS. DURING DEPLOYMENT OF THE VIABAHN THE DEPLOYMENT LINE BROKE LEAVING A PORTION OF THE DEVICE CONSTRAINED. IT WAS REPORTED AS THE DELIVERY SYSTEM WAS REMOVED FROM THE PATIENT THE STENT GRAFT COMPLETELY EXPANDED. HOWEVER, A PORTION OF THE DEPLOYMENT LINE WAS LEFT IN THE PATIENT. THE PHYSICIAN STATED THE SUSPECTED CAUSE OF THE DEPLOYMENT LINE BREAK IS UNKNOWN. THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Foreign Body In Patient; No Known Impact Or Consequence To Patient
MAUDE report 10374625 ↗InjurySep 6, 2018Complete Blockage; Off-Label Use; Complete Blockage; Off-Label Use
IT WAS REPORTED TO GORE THAT ON (B)(6) 2018, A PATIENT WAS TREATED FOR A LEFT LEG POPLITEAL ARTERY ANEURYSM USING TWO GORE® VIABAHN® ENDOPROSTHESES WITH HEPARIN BIOACTIVE SURFACE. THE PATIENT REPORTED HIS LEG FELT BETTER FOR A PERIOD OF TIME AFTER THE (B)(6)PROCEDURE, BUT HIS LEG DID NOT IMPROVE AS HE HAD HOPED. IT WAS REPORTED THE SWELLING IN THE PATIENT¿S LEFT LEG DID NOT DECREASE, AND HE EXPERIENCED A FAIR AMOUNT OF DISCOMFORT THAT VARIED DAY BY DAY. THE PATIENT REPORTED THAT ON (B)(6) 2018, HE PRESENTED TO HIS LOCAL EMERGENCY ROOM WITH LEG DISCOLORATION, INTENSE CRAMPING, AND PAIN IN HIS LEFT LEG, AND IT WAS REPORTEDLY DETERMINED THERE WAS NO CIRCULATION BELOW THE PATIENT¿S LEFT KNEE. IT WAS FURTHER REPORTED THAT IMAGING SHOWED THE TWO GORE® VIABAHN® ENDOPROSTHESES WERE OCCLUDED. ACCORDING TO THE REPORT, THE HOSPITAL EMERGENTLY TRANSFERRED THE PATIENT VIA AIR EVACUATION TO INDIANA UNIVERSITY HEALTH METHODIST HOSPITAL, WHERE THE PATIENT WAS ADMITTED FOR TREATMENT OF THE OCCLUSION. IT WAS REPORTED TO THE PATIENT THAT A RADIOLOGIST ATTENDING TO THE PATIENT DURING HIS (B)(6) 2018 VISIT STATED HIS STENTS DID NOT OCCLUDE ALL AT ONCE, AND THAT THE OCCLUSION WAS A GRADUAL PROCESS. IT W
Patient problems: Cramp(s); Ischemia; Numbness; Pain; Skin Discoloration
MAUDE report 7853989 ↗
Other System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment devices
- COVERA AVSM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall33 reports
- COVERA AVSM08060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall21 reports
- COVERA AVSM09060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall18 reports
- COVERA AVSM10080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall16 reports
- COVERA AVSM10040Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall15 reports
- COVERA AVFM10060Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall14 reports
- COVERA AVSM09080Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall1 death14 reports
- COVERA AVSM10100Angiomed GmbH & Co. Medizintechnik KG · System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment1 recall13 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page